Quantum Biopharma Ltd. Class B Subordinate Voting Shares (QNTM)
Stock · NASDAQ · Health Care
$3.08as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Resistance level
$3.62
Industry
Biotechnology: Pharmaceutical Preparations
About QNTM
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of de…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Website
- www.quantumbiopharma.com
Fundamentals
- 1-day range
- $3.31$3.95
- Market cap
- $19.52M
- P/E (trailing)
- —
- P/E (forward)
- -0.49
- EPS (trailing)
- $-7.73
- Dividend yield
- —
- Beta
- —
- Avg. volume
- 270.6K
52-week range
$2.07$22.47
Quantum Biopharma Ltd. Class B Subordinate Voting Shares Competitors
Chosen by industry and closest market cap.
- QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares$3.08▼ 1.76%Market cap $19.52MP/E —$2.07$22.47
- ALLRAllarity Therapeutics Inc. Common Stock$1.41▲ 2.17%Market cap $19.64MP/E —$0.769$2.06
- PLRZPolyrizon Ltd. Ordinary Shares$12.7▼ 0.78%Market cap $19.82MP/E —$2.88$18.2
- DAREDare Bioscience Inc. Common Stock$0.7437▲ 0.64%Market cap $19.17MP/E —$0.72$3.78
- MRKRMarker Therapeutics Inc. Common Stock$1.37▼ 7.12%Market cap $20.34MP/E —$0.8099$2.46
- SKYESkye Bioscience Inc. Common Stock$1.81▼ 7.18%Market cap $20.53MP/E —$1.84$39.92
- NCELNewcelX Ltd. Ordinary Shares$3.19▼ 6.73%Market cap $18.41MP/E —$1.83$24.6
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| QNTM Quantum Biopharma Ltd. Class B Subordinate Voting Shares | $19.52M | — | $3.08 | ▼ 1.76% | $2.07$22.47 |
| ALLR Allarity Therapeutics Inc. Common Stock | $19.64M | — | $1.41 | ▲ 2.17% | $0.769$2.06 |
| PLRZ Polyrizon Ltd. Ordinary Shares | $19.82M | — | $12.7 | ▼ 0.78% | $2.88$18.2 |
| DARE Dare Bioscience Inc. Common Stock | $19.17M | — | $0.7437 | ▲ 0.64% | $0.72$3.78 |
| MRKR Marker Therapeutics Inc. Common Stock | $20.34M | — | $1.37 | ▼ 7.12% | $0.8099$2.46 |
| SKYE Skye Bioscience Inc. Common Stock | $20.53M | — | $1.81 | ▼ 7.18% | $1.84$39.92 |
| NCEL NewcelX Ltd. Ordinary Shares | $18.41M | — | $3.19 | ▼ 6.73% | $1.83$24.6 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- These stocks are moving in today's pre-market sessionChartMill · 8/17/2026
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga · 8/17/2026
- EXCLUSIVE: Quantum BioPharma Achieves Major Milestone With FDA Clearance for Multiple Sclerosis TrialBenzinga · 8/10/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 254.3K
- Total value held
- $1.17M
- Institutional holders
- 25
Top holders this quarter
- Unknown108.6K
- Unknown41.1K
- Unknown31.5K
- Unknown15.9K
- Unknown13.5K
- Unknown12.3K
- Unknown10.1K
- Unknown7.2K
- Unknown6.4K
- Unknown4.4K
See the full, filterable feed with live charts on the MarketWall dashboard.